EVOMELA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cenexi - Bla. The primary component is Melphalan Hydrochloride.
| Product ID | 69605-001_d44fac6f-e1e1-399d-e053-2a95a90a81f1 | 
| NDC | 69605-001 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | EVOMELA | 
| Generic Name | Melphalan | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2016-03-31 | 
| Marketing Category | NDA / | 
| Application Number | NDA207155 | 
| Labeler Name | CENEXI - BLA | 
| Substance Name | MELPHALAN HYDROCHLORIDE | 
| Active Ingredient Strength | 50 mg/10mL | 
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2016-03-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 68152-109 | EVOMELA | Melphalan | 
| 69605-001 | EVOMELA | Melphalan | 
| 72893-001 | EVOMELA | Melphalan | 
| 52609-0001 | ALKERAN | melphalan | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() EVOMELA  86508057  4994159 Live/Registered  | 
        ACROTECH BIOPHARMA LLC  2015-01-20  |